EN DE
STOCK COMPARISON

WuXi XDC Cayman vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how WuXi XDC Cayman (2268) and Thermo Fisher Scientific (TMO) compare, as of Oct 1, 2026.

As of Oct 1, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the more attractively valued of the two: WuXi XDC Cayman trades at HK$82.00 versus a fair value of HK$43.22 (−47.3%), while Thermo Fisher Scientific trades at $675 versus $686 (+1.6%).
WuXi XDC Cayman
2268.HK · HKD · Materials
−47.3%
upside to fair value
overvalued
PriceHK$82.00
Fair ValueHK$43.22
Quality52/100
Thermo Fisher Scientific
TMO · USD · Health Care
+1.6%
upside to fair value
fairly valued
Price$675
Fair Value$686
Quality62/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

WuXi XDC CaymanThermo Fisher Scientific
Valuation
45.6×P/E (TTM)36.0×
32.3×Forward P/E (FY2027)24.5×
n/aMedian P/E at FY-end (10 FY, ex one-offs where documented)31.6×
15.62×P/S (TTM)5.41×
8.65×P/B4.69× · book value is mostly goodwill
51.7×EV/EBITDA23.6×
n/aPEG1.96×
−47.3%Fair value upside+1.6%
n/aDividend yield0.3%
n/aDividend per share$1.80
Profitability
26.3%Operating margin18.8%
n/aEBIT margin trend (5Y)0.74×
17.1%Return on equity13.5%
8.6%Return on assets5.1%
Growth
35.9%Revenue growth (YoY)10.5%
81.7%Avg. growth/yr (3Y)-0.3%
n/aAvg. growth/yr (5Y)6.7%
n/aValue creation/yr+2.6%
Balance & size
95.5×Interest coverage (EBIT/interest)5.7×
0.00×Debt / equity0.67×
$14BMarket cap$250B
mixedGrowth qualityhealthy
Thermo Fisher Scientific, median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, 6 of the years ex one-offs: 31.6.
Forward P/E: price divided by the analyst consensus for the first fiscal year that has not started yet. The current year carries special items from quarters already reported.
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

WuXi XDC Cayman leads: 5 to 2 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

WuXi XDC Caymanof which business quality 53 · market factors 67 Thermo Fisher Scientificof which business quality 60 · market factors 81
ProfitabilityMargins and returns on capital today
54
43
Quality GrowthAre margins and returns improving?
57
31
CashflowEarnings quality: real cash, not paper profit
51
62
Fin. StrengthBalance sheet, leverage, solvency risk
86
60
InvestmentDisciplined investing over empire-building
0
79
Low VolatilityCalm price path (market factor)
56
70
MomentumPrice trend over the last 3–12 months (market factor)
71
83
52W MomentumDistance to the 52-week high (market factor)
72
92
Net IssuanceShare count: buybacks or dilution?
46
97

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyWuXi XDC CaymanPrice HK$82.00Thermo Fisher ScientificPrice $675
DCF Models−74.9%below the priceHK$20.60−38.9%below the price$413
Earnings-Based−41.4%below the priceHK$48.04−69.8%below the price$204
Multiples−75.4%below the priceHK$20.14−54.1%below the price$310
Asset-Based−91.9%below the priceHK$6.66−85.7%below the price$96.78
Growth DCF−79.2%below the priceHK$17.08−46.6%below the price$361
Economic Profit−79.3%below the priceHK$16.98−73.8%below the price$177
Growth Earnings−27.9%below the priceHK$59.10−49.2%below the price$343
Minimum−91.9%below the priceHK$6.66−85.7%below the price$96.78
Maximum−27.9%below the priceHK$59.10−38.9%below the price$413
Median−75.4%below the priceHK$20.14−54.1%below the price$310
Geometric mean−73.5%below the priceHK$21.71−63.5%below the price$246

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

WuXi XDC Cayman: 24 of 24 models see the stock below the current price.

Thermo Fisher Scientific: 24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

WuXi XDC Cayman
Price HK$82.00
Fair Value HK$43.22
Bear HK$28.70Bull HK$53.74
Thermo Fisher Scientific
Price $675
Fair Value $686
Bear $414Bull $892

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

WuXi XDC Cayman · Materials

Quality score52 · above median
Fair value upside−47.3% · below median

Thermo Fisher Scientific · Health Care

Quality score62 · above median
Fair value upside+1.6% · above median

Bottom line

As of Oct 1, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the more attractively valued of the two: WuXi XDC Cayman trades at HK$82.00 versus a fair value of HK$43.22 (−47.3%), while Thermo Fisher Scientific trades at $675 versus $686 (+1.6%).

Thermo Fisher Scientific has the higher quality score (62/100).

Open Thermo Fisher Scientific live analysis →
WuXi XDC Cayman · Thermo Fisher Scientific

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to WuXi XDC Cayman

Microsoft vs NvidiaApple vs MicrosoftMicrosoft vs Taiwan Semiconductor ManufacturingAlphabet Inc Class C vs Meta Platforms

Related to Thermo Fisher Scientific

Eli Lilly and vs UnitedHealth GroupBroadcom vs MicrosoftMicrosoft vs Micron TechnologyAdvanced Micro Devices vs Microsoft
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.